Delivery Order SPE2DR25D3404-SPE2DR26F5U8D
Award Date 12/19/25
Potential Completion Date 12/22/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $37,212.19 to AmerisourceBergen Drug Corp for the supply of Activase 100 mg vials, with a completion date of December 1, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,468.70 to AmerisourceBergen Drug Corp for the supply of Activase 50mg injection on December 18, 2025, with an ultimate completion date of January 16, 2026. This firm fixed-price contract, issued without set-aside provisions, represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials, valued at $12,474.24 under a firm fixed-price contract. The award was issued on June 2, 2025, with an ultimate completion date of June 3, 2025, and represents a non-set-aside, competitively awarded contract. AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,595.40 to AmerisourceBergen Drug Corp for the supply of Activase 100 mg vials, with an ultimate completion date of September 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,676.32 to AmerisourceBergen Drug Corp for the supply of Activase 100 mg vials, with an ultimate completion date of September 12, 2025. This firm fixed-price, non-set-aside contract was awarded competitively on September 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $15,172.51 to AmerisourceBergen Drug Corp for the supply of Activase 100 mg vials. This firm fixed-price contract, awarded on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $20,483.72 to AmerisourceBergen Drug Corp for the supply of Activase 100 mg vials on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $6,237.63 to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Activase 100 mg vials, with an ultimate completion date of November 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $33,311.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Activase 100 mg vials, with performance completion targeted for October 29, 2025. The award, issued without a set-aside designation, reflects open competitive procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $22,365.75 to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials. This firm fixed price contract, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was made through competitive procurement with no set-aside designation. Performance will take place at...